Connection Vol. 15: HER2 in Gastric Cancer

Gastric cancer is the fourth most commonly diagnosed cancer. Recently, Trastuzumab® has been shown to improve the survival of patients with advanced gastric cancer. Dako also received approval from the U.S. FDA to expand the intended use for HercepTest™ and HER2 FISH pharmDx™ Kit to include patients with metastatic gastric or gastroesophageal junction adenocarcinoma. This issue of Connection is especially dedicated to inform and update both the practitioners and observers about the the emerging use of Trastuzumab® in gastric cancer, pharmacodiagnostics, and the salient differences between breast and gastric cancer HER2 testing.

Download the full Connection Vol. 15
Literature Order No. 28830

All articles that have been brought in Connection Vol. 15 are available below:

Connection 15 Articles

Editorial - HER2 in Gastric Cancer
Dec 14, 2010

Featured Laboratory - Queen Elizabeth Hospital
Dec 14, 2010

Breast vs. Gastric Cancer
Dec 14, 2010

Gastric Carcinoma
Dec 14, 2010

Overview of Trastuzumab's Utility for Gastric Cancer
Dec 14, 2010

HER2 Diagnostics in Gastric Cancer
Dec 14, 2010

Developing Pharmacodiagnostics for HER2 Postive Gastric Cancer
Dec 14, 2010

HER2 Testing in Gastric Cancer and Esophageal Adenocarcinoma: Emerging Therapeutic Options and Diagnostic Challenges
Dec 14, 2010

The ToGA (Trastuzumab for GAstric Cancer) Trial: Importance from a Biomarker Perspective
Dec 14, 2010

Gastric Cancer Treatment in Japan
Dec 14, 2010

HER2 Status: What is the Difference Between Breast and Gastric Cancer
Dec 14, 2010

HER2 Testing in Gastric / Gastro-Esophageal Junction Adenocarcinomas and Breast Cancer: Similiarities
Dec 14, 2010

Country selection

Your Dako Account indicates that you are based in , you will be transfered to the web site for

Basket emptied

Your basket was emptied because of the country change.

Country selection

United States of America appears to be your location. To view country specific information on the Dako web site, please accept or change country below.


Dako Cookie Policy
This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. Privacy Statement



Get in Touch with Dako in Luxemburg

Contact Us Directly

info.be@dako.com
+32 016/38.72.20
+32 016/38.72.21

Pathology Products, Flow Cytometry Products and Specific Proteins
Please inquire at
Dako Belgium N.V.

Interleuvenlaan 12B
B-3001 Heverlee
Belgium

Detailed contact information

Submit an Inquiry

How would you like us to follow up?


Your session expired

You have been logged out. Log in again to retrieve your Cart.